Dyadic International, Inc. (DYAI)Healthcare | Biotechnology | Jupiter, United States | NasdaqCM
0.41 USD
-0.01
(-1.979%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 0.40 -0.01 (-0.011%) ⇩ (Oct. 16, 2026, 4:56 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 1:29 a.m. EDT
Dyadic International presents a severe fundamental distress scenario that overrides any potential speculative bounce. The company is hemorrhaging cash, with operating and free cash flows deeply negative, while revenue has stagnated and profitability remains nonexistent. The balance sheet is compromised, showing negative book value and debt exceeding cash reserves, forcing the company to rely on capital markets for survival rather than organic growth. Although the stock recently regained Nasdaq compliance, this regulatory reprieve does not address the core business rot; the company is merely delaying the inevitable delisting or bankruptcy without a viable path to profitability. The massive discrepancy between the current price and the analyst mean target is a dangerous illusion, reflecting a hope for a miracle turnaround rather than a grounded investment thesis. With no dividend to provide income and a trajectory of declining fundamentals, this is a high-risk speculative vehicle best avoided by rational investors. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.540182 |
| MSTL | 0.565080 |
| AutoTheta | 0.796421 |
| AutoARIMA | 0.843718 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 44.63 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.219 |
| Excess Kurtosis | -1.27 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.106 |
| Market Cap | 16,470,189 |
| Forward P/E | -1.28 |
| Beta | 0.96 |
| Profit Margins | -200.46% |
| Website | https://www.dyadic.com |
As of Oct. 10, 2026, 1:29 a.m. EDT: Options activity is virtually dormant with negligible open interest and volume across both calls and puts. Implied volatility is extremely low (near zero) for out-of-the-money strikes, indicating a complete lack of speculative positioning or hedging demand. The absence of any significant flow suggests the market has effectively priced the asset as having no near-term catalysts or liquidity.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6074766 |
| Address1 | 1,044 North U.S. Highway One |
| Address2 | Suite 201 |
| All Time High | 10.98 |
| All Time Low | 0.05 |
| Ask | 0.5801 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 119,620 |
| Average Daily Volume3 Month | 189,292 |
| Average Volume | 189,292 |
| Average Volume10Days | 119,620 |
| Beta | 0.96 |
| Bid | 0.322 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | -0.066 |
| City | Jupiter |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4111 |
| Current Ratio | 1.65 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.4259 |
| Day Low | 0.39 |
| Display Name | Dyadic |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,568,400 |
| Earnings Call Timestamp Start | 1,786,568,400 |
| Earnings Timestamp | 1,786,537,800 |
| Earnings Timestamp End | 1,794,400,200 |
| Earnings Timestamp Start | 1,794,400,200 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 4.528 |
| Enterprise Value | 17,214,738 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -0.23 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 561 743 8343 |
| Fifty Day Average | 0.5686 |
| Fifty Day Average Change | -0.1575 |
| Fifty Day Average Change Percent | -0.27699614 |
| Fifty Two Week Change Percent | -60.747658 |
| Fifty Two Week High | 1.6 |
| Fifty Two Week High Change | -1.1889 |
| Fifty Two Week High Change Percent | -0.7430625 |
| Fifty Two Week Low | 0.34 |
| Fifty Two Week Low Change | 0.0711 |
| Fifty Two Week Low Change Percent | 0.20911764 |
| Fifty Two Week Range | 0.34 - 1.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,200,493,800,000 |
| Float Shares | 27,495,552 |
| Forward Eps | -0.32 |
| Forward P E | -1.2846875 |
| Free Cashflow | -4,809,161 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Fullday Change | -0.0194 |
| Fullday Change Percent | -4.6256557 |
| Fullday Price | 0.4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.16244 |
| Gross Profits | 617,621 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.22896999 |
| Held Percent Institutions | 0.20813999 |
| Implied Shares Outstanding | 40,063,703 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. |
| Long Name | Dyadic International, Inc. |
| Market | us_market |
| Market Cap | 16,470,189 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_4272801 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -7,621,842 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,622,430 |
| Number Of Analyst Opinions | 2 |
| Open | 0.419 |
| Operating Cashflow | -7,403,841 |
| Operating Margins | -2.12822 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 561 743 8333 |
| Post Market Change | -0.011099994 |
| Post Market Change Percent | -2.7000716 |
| Post Market Price | 0.4 |
| Post Market Time | 1,792,184,213 |
| Previous Close | 0.4194 |
| Price Hint | 4 |
| Price To Book | -6.228788 |
| Price To Sales Trailing12 Months | 4.3317103 |
| Profit Margins | -2.00457 |
| Quick Ratio | 1.141 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.008300006 |
| Regular Market Change Percent | -1.9790192 |
| Regular Market Day High | 0.4259 |
| Regular Market Day Low | 0.39 |
| Regular Market Day Range | 0.39 - 0.4259 |
| Regular Market Open | 0.419 |
| Regular Market Previous Close | 0.4194 |
| Regular Market Price | 0.4111 |
| Regular Market Time | 1,792,180,801 |
| Regular Market Volume | 78,278 |
| Return On Assets | -0.62994 |
| Revenue Growth | -0.006 |
| Revenue Per Share | 0.106 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 40,063,703 |
| Shares Percent Shares Out | 0.0045 |
| Shares Short | 179,040 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 174,707 |
| Short Name | Dyadic International, Inc. |
| Short Percent Of Float | 0.0052 |
| Short Ratio | 0.81 |
| Source Interval | 15 |
| State | FL |
| Symbol | DYAI |
| Target High Price | 7.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 5.5 |
| Target Median Price | 5.5 |
| Total Cash | 3,113,719 |
| Total Cash Per Share | 0.085 |
| Total Debt | 5,046,064 |
| Total Revenue | 3,802,237 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.23 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.7906 |
| Two Hundred Day Average Change | -0.3795 |
| Two Hundred Day Average Change Percent | -0.4800152 |
| Type Disp | Equity |
| Volume | 78,278 |
| Website | https://www.dyadic.com |
| Zip | 33,477-5094 |